Is ATHA A Good Stock To Buy According To Hedge Funds?
A whopping number of 13F filings filed with U.S.
Athira Pharma Inc. (ATHA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 5,402,964 | $1,539,304 | 0.05% | |
| 2. | Propel Bio Management Leen Kawas And Richard Kayne | 1,492,792 | $425,296 | 0.49% | |
| 3. | Tang Capital Management Kevin C. Tang | 600,000 | $170,940 | 0.01% | |
| 4. | Renaissance Technologies Jim Simons | 219,000 | $62,393 | +6% | 0% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 157,100 | $44,758 | -38% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.42 | 27,400 | $66,179.22 | 80,715 | 2024-06-24 | Filing | |
| $2.26 | 15,000 | $33,871.50 | 53,315 | 2024-06-21 | Filing | |
| $2.38 | 163,954 | $390,210.52 | 5,402,964 | 2023-12-29 | Filing | |
| $2.44 | 409,598 | $999,419.12 | 5,239,010 | 2023-12-28 | Filing | |
| $2.28 | 32,134 | $73,265.52 | 4,829,412 | 2023-12-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.56 | 10,826 | $6,083.13 | 35,841 | 2025-01-02 | Filing | |
| $0.56 | 25,107 | $14,107.62 | 242,591 | 2025-01-02 | Filing | |
| $0.56 | 8,510 | $4,781.77 | 130,761 | 2025-01-02 | Filing | |
| $0.56 | 2,881 | $1,618.83 | 89,724 | 2025-01-02 | Filing | |
| $0.56 | 8,510 | $4,781.77 | 83,735 | 2025-01-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,200,667 | $911,870 | 0.74% | |
| 2. | 1,537,914 | $438,306 | 0% | |
| 3. | 1,492,792 | $425,296 | 0.02% | |
| 4. | 457,199 | $130,256 | 0% | |
| 5. | 416,158 | $118,189 | 0% |
News See All
Billionaire Hedge Funds
